Common use of Medical Devices Clause in Contracts

Medical Devices. If any of the Products are medical devices, Buyer acknowledges that it is familiar with the U.S. Safe Medical Devices Act of 1990 (the “Devices Act”) and the reporting obligations imposed on device users thereunder. In this regard, Buyer agrees to notify Crosstex within 10 days of the occurrence of any event identified in the Devices Act imposing a reporting obligation on Buyer and/or Crosstex (except for events representing an imminent hazard that require notification to the U.S. Food and Drug Administration (the “FDA”) within 72 hours (or such shorter time as required by law), in which case, such notice will be delivered to the FDA and Crosstex within said period). Buyer will maintain adequate tracking for the Products to enable Crosstex to meet the FDA requirements applicable to the tracking of medical devices.

Medical Devices. If any of the Products are medical devices, Buyer acknowledges that it is familiar with the U.S. Safe Medical Devices Act of 1990 (the “Devices Act”) and the reporting obligations imposed on device users thereunder. In this regard, Buyer Xxxxx agrees to notify Crosstex within 10 days of the occurrence of any event identified in the Devices Act imposing a reporting obligation on Buyer and/or Crosstex (except for events representing an imminent hazard that require notification to the U.S. Food and Drug Administration (the “FDA”) within 72 hours (or such shorter time as required by law), in which case, such notice will be delivered to the FDA and Crosstex within said period). Buyer will maintain adequate tracking for the Products to enable Crosstex to meet the FDA requirements applicable to the tracking of medical devices.

Medical Devices. If any of the Products are medical devices, Buyer acknowledges that it is familiar with the U.S. Safe Medical Devices Act of 1990 (the “Devices Act”) and the reporting obligations imposed on device users thereunder. In this regard, Buyer Xxxxx agrees to notify Crosstex Evoqua within 10 ten (10) days of the occurrence of any event identified in the Devices Act imposing a reporting obligation on Buyer and/or Crosstex Evoqua (except for events representing an imminent hazard that require notification to the U.S. United States Food and Drug Administration (the “FDA”) within 72 seventy-two (72) hours (or such shorter time as required by law), in which case, such notice will be delivered to the FDA and Crosstex Evoqua within said period). Buyer will maintain adequate tracking for the Products to enable Crosstex Evoqua to meet the FDA requirements applicable to the tracking of medical devices.

Medical Devices. If any of the Products are medical devices, Buyer acknowledges that it is familiar with the U.S. Safe Medical Devices Act of 1990 (the “Devices Act”) and the reporting obligations imposed on device users thereunder. In this regard, Buyer agrees to notify Crosstex Mar Cor within 10 ten (10) days of the occurrence of any event identified in the Devices Act imposing a reporting obligation on Buyer and/or Crosstex Mar Cor (except for events representing an imminent hazard that require notification to the U.S. United States Food and Drug Administration (the “FDA”) within 72 seventy-two (72) hours (or such shorter time as required by law), in which case, such notice will be delivered to the FDA and Crosstex Mar Cor within said period). Buyer will maintain adequate tracking for the Products to enable Crosstex Mar Cor to meet the FDA requirements applicable to the tracking of medical devices.

Medical Devices. If any of the Products are medical devices, Buyer acknowledges that it is familiar with the U.S. Safe Medical Devices Act of 1990 (the “Devices Act”) and the reporting obligations imposed on device users thereunder. In this regard, Buyer agrees to notify Crosstex Evoqua within 10 ten (10) days of the occurrence of any event identified in the Devices Act imposing a reporting obligation on Buyer and/or Crosstex Evoqua (except for events representing an imminent hazard that require notification to the U.S. United States Food and Drug Administration (the “FDA”) within 72 seventy- two (72) hours (or such shorter time as required by law), in which case, such notice will be delivered to the FDA and Crosstex Evoqua within said period). Buyer will maintain adequate tracking for the Products to enable Crosstex Evoqua to meet the FDA requirements applicable to the tracking of medical devices.

Medical Devices. If any of the Products are medical devices, Buyer acknowledges that it is familiar with the U.S. Safe Medical Devices Act of 1990 (the “Devices Act”) and the reporting obligations imposed on device users thereunder. In this regard, Buyer agrees to notify Crosstex MEDIVATORS within 10 ten (10) days of the occurrence of any event identified in the Devices Act imposing a reporting obligation on Buyer and/or Crosstex MEDIVATORS (except for events representing an imminent hazard that require notification to the U.S. United States Food and Drug Administration (the “FDA”) within 72 seventy-two (72) hours (or such shorter time as required by law), in which case, such notice will be delivered to the FDA and Crosstex MEDIVATORS within said period). Buyer will maintain adequate tracking for the Products to enable Crosstex MEDIVATORS to meet the FDA requirements applicable to the tracking of medical devices.